1. Home
  2. VMI vs KNSA Comparison

VMI vs KNSA Comparison

Compare VMI & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valmont Industries Inc.

VMI

Valmont Industries Inc.

N/A

Current Price

$385.66

Market Cap

7.4B

Sector

Industrials

ML Signal

N/A

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

N/A

Current Price

$93.90

Market Cap

7.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VMI
KNSA
Founded
1946
2015
Country
United States
United Kingdom
Employees
10791
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.7B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
VMI
KNSA
Price
$385.66
$93.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
★ $610.75
$111.57
AVG Volume (30 Days)
162.5K
★ 800.1K
Earning Date
10-20-2026
10-27-2026
Dividend Yield
★ 0.75%
N/A
EPS Growth
N/A
★ 225.00
EPS
★ 17.88
1.14
Revenue
★ $3,169,556,000.00
$677,564,000.00
Revenue This Year
$6.09
$54.80
Revenue Next Year
$7.43
$28.50
P/E Ratio
★ $22.93
$82.02
Revenue Growth
14.52
★ 60.09
52 Week Low
$379.28
$37.02
52 Week High
$585.71
$99.31

Technical Indicators

Market Signals
Indicator
VMI
KNSA
Relative Strength Index (RSI) 30.31 55.79
Support Level N/A $87.30
Resistance Level $487.35 $98.90
Average True Range (ATR) 13.46 3.99
MACD -0.86 -0.60
Stochastic Oscillator 2.31 54.12

Price Performance

Historical Comparison
VMI
KNSA

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting, transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: